The feasibility of pharmacy-based naloxone distribution interventions: A qualitative study with injection drug users and pharmacy staff in Rhode Island

Substance Use and Misuse

Volumn 48, Issue 8, 2013, Pages 590-599

  Zaller, Nickolas D ^a   Yokell, Michael A ^b   Green, Traci Craig ^c   Gaggin, Julia ^d   Case, Patricia ^d  

^a MIRIAM HOSPITAL   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BROWN UNIVERSITY   (United States)

^d FENWAY INSTITUTE   (United States)

Author keywords

IDU; Injection drug user; Naloxone; Overdose; Pharmacy

Indexed keywords

NALOXONE; NARCOTIC ANTAGONIST;

ADULT; ARTICLE; ATTITUDE TO HEALTH; DRUG OVERDOSE; DRUG USE; FEASIBILITY STUDY; FEMALE; HUMAN; MALE; OPIATE ADDICTION; ORGANIZATION AND MANAGEMENT; PHARMACIST; PHARMACY; PSYCHOLOGICAL ASPECT; QUALITATIVE RESEARCH; SUBSTANCE ABUSE; UNITED STATES;

ADULT; COMMUNITY PHARMACY SERVICES; DRUG OVERDOSE; DRUG USERS; FEASIBILITY STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; NALOXONE; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; PHARMACIES; PHARMACISTS; QUALITATIVE RESEARCH; RHODE ISLAND; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84879179106     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826084.2013.793355     Document Type: Article

References (27)

1. Centers for Disease Control and Prevention (CDC). (2010). Morbidity and mortality weekly report (MMWR). Unintentional drug poisoning in the United States, 1-4.
2. Chein, I. (Ed.). (1981). An introduction to sampling. (4th ed). Austin: Holt, Rinehart and Winston.
3. Darbekova, G., Kozachenko, N., Mingazova, I., Solodov, A., Kartaschova, N., Lazzarini, Z., et al. (2007). Legal treatment of preventive work with injection drug users in Temirtau, Kazakhstan (abstract #1005). Paper presented at the 18th International Harm Reduction Conference. Warsaw, Poland.
4. Doe-Simkins, M., Walley, A. Y., Epstein, A., & Moyer, P. (2009). Saved by the nose: Bystander-administered intranasal naloxone hydrochloride for opioid overdose. American Journal of Public Health, 99(5), 788-791.
5. Glaser, B., & Strauss, A. (1967). The discovery of grounded theory. Chicago: Aldine.
6. Grabenstein, J. D. (1998). Pharmacists as vaccine advocates; roles in community pharmacies, nursing homes, and hospitals. Vaccine, 16, 1705-1710.
7. Green, T. C., Heimer, R.,&Grau, L. E. (2008). Distinguishing signs of opioid overdose and indication for naloxone: An evaluation of six overdose training and naloxone distribution programs in the United States. Addiction, 103(6),979-989.
8. Haas, C. E., Eckel, S., Arif, S., Beringer, P. M., Blake, E. W., Lardieri, A. B., et al. (2012). Acute care clinical pharmacy practice: Unit-versus service-based models. Pharmacotherapy, 32(2), e35-44.
9. Kalister, H., Newman, R. D., Read, L., Walters, C., Hrachovec, J., & Graham, E. A. (1999). Pharmacy-based evaluation and treatment of minor illnesses in a culturally diverse pediatric clinic. Archives of Pediatrics and Adolescent Medicine, 153, 731-735.
10. Kerr, D., Kelly, A.-M., Dietze, P., Jolley, D., & Barger, B. (2009). Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose. Addiction, 104(12), 2067-2074.
11. Khoshnood, K., Blankenship, K. M., Pollack, H. A., Roan, C. T., & Altice, F. L. (2000). Syringe source, use, and discard among injection-drug users in New Haven, Connecticut. AIDS Public Policy Journal, 15(3-4), 88-94.
12. Kim, D., Irwin, K. S.,&Khoshnood, K. (2009). Expanded access to naloxone: options for critical response to the epidemic of opioid overdose mortality. American Journal of Public Health, 99(3), 402-407.
13. Kitsenko, N.,&Kitsenko, G. (2007). Acontinuing epidemic of HIV among IDUs in Odessa, Ukraine: Insights from a Rapid Policy Assessment (abstract #1064). Paper presented at the 18th International Harm Reduction Conference. Warsaw, Poland.
14. Kitsenko, G., Kitsenko, N., Ysipenko, T., Lazzarini, Z., Burris, S., & Case, P. (2007). Drug law and the practice of its application in Ukraine in terms of harm reduction (abstract #1065). Paper presented at the 18th International Harm Reduction Conference. Warsaw, Poland.
15. Mangum, S. A., Kraenow, K. R., & Narducci, W. A. (2003). Identifying at-risk patients through community pharmacy-based hypertension and stroke prevention screening project. Journal of the American Pharmacists Association, 43(1), 50-55.
16. Merriam, S. (2001). Qualitative research and case study applications in education. San Francisco: Jossey-Bass.
17. Piper, T. M., Stancliff, S., Rudenstine, S., Sherman, S., Nandi, V., Clear, A., et al. (2008). Evaluation of a Naloxone Distribution and Administration Program in New York City. Substance Use & Misuse, 43(7), 858-870.
18. Riley, E. D., Kral, A. H., Stopka, T. J., Garfein, R. S., Reuckhaus, P., & Bluthenthal, R. N. (2010). Access to sterile syringes through San Francisco Pharmacies and the association with HIV risk behavior among injection drug users. Journal of Urban Health, 87(4), 543-542.
19. Rudolph, A. E., Crawford, N. D., Ompad, D. C., Benjamin, E. O., Stern, R. J., & Fuller, C. M. (2010). Comparison of injection drug users accessing syringes from pharmacies, syringe exchange programs, and other syringe sources to inform targeted HIV prevention and intervention strategies. Journal of the American Pharmacists Association, 50(2), 140-147.
20. Seal, K. H., Thawley, R., Gee, L., Bamberger, J., Kral, A. H., Ciccarone, D., et al. (2005). Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: A pilot intervention study. Journal of Urban Health, 82(2), 303-311.
21. Sporer, K. A., & Kral, A. H. (2007). Prescription naloxone: A novel approach to heroin overdose prevention. Annals Emergency Medicine, 49(2), 172-177.
22. Strauss, A, & Corbin, J. (1998). Basics of qualitative research: Techniques and procedures for developing grounded theory. Thousand Oaks: Sage. Physicians' Desk Reference. 53rd ed. (2009). Montvale, NJ: Medical Economics Company.
23. Vyshemirskaya, I., Kross, A., Osipenko, V., Burkhanova, O., Burris, S., Case, P., et al. (2007). Legal and policy barriers to effective health interventions among IDUs in Kaliningrad, Russia: Results of a Rapid Policy Assessment and Response Intervention (abstract #975). Paper presented at the 18th International Harm Reduction Conference.
24. Warsaw, Poland. Wagner, K. D., Valente, T., Casanova, M., Partovi, S. M., Mendenhall, B., Hundley, J., et al. (2010). Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA. International Journal of Drug Policy, 21(3), 186-193.
25. Warner-Smith, M., Darke, S., Lynskey, M., & Hall, W. (2001). Heroin overdose: causes and consequences. Addiction, 96(8), 1113-1125.
26. Youchun, Z., Davis, C., & Xiaoxing, F. (2007). Rapid assessment of the legal and policy risk environment for IDUs in Urumqi and Heng Chien, China (abstract #972). Paper presented at the 18th International Harm Reduction Conference. Warsaw, Poland.
27. Zaller, N. D., Yokell, M. A., Nayak, S. M., Fu, J. J., Bazazzi, A. R., & Rich, J. D. (2012). Syringe acquisition experiences among injection drug users undergoing short-term opioid detoxification in Massachusetts and Rhode Island. Journal of Urban Health, 89(4), 659-670.